Literature DB >> 31463683

Metabolomics by UHPLC-MS: benefits provided by complementary use of Q-TOF and QQQ for pathway profiling.

Katrin Freiburghaus1, Carlo Rodolfo Largiadèr1, Christoph Stettler2, Georg Martin Fiedler1, Lia Bally2, Cédric Bovet3.   

Abstract

INTRODUCTION: Non-targeted metabolic profiling using high-resolution mass spectrometry (HRMS) is a standard approach for pathway identification despite technical limitations.
OBJECTIVES: To assess the performance of combining targeted quadrupole (QQQ) analysis with HRMS for in-depth pathway profiling.
METHODS: Serum of exercising patients with type 1 diabetes (T1D) was profiled using targeted and non-targeted assays.
RESULTS: Non-targeted analysis yielded a broad unbiased metabolic profile, targeted analysis increased coverage of purine metabolism (twofold) and TCA cycle (three metabolites).
CONCLUSION: Our screening strategy combined the benefits of the unbiased full-scan HRMS acquisition with the deeper insight into specific pathways by large-scale QQQ analysis.

Entities:  

Keywords:  Metabolism; Non-targeted; Pathways; Targeted

Mesh:

Substances:

Year:  2019        PMID: 31463683     DOI: 10.1007/s11306-019-1585-3

Source DB:  PubMed          Journal:  Metabolomics        ISSN: 1573-3882            Impact factor:   4.290


  16 in total

1.  Metabolic signatures of exercise in human plasma.

Authors:  Gregory D Lewis; Laurie Farrell; Malissa J Wood; Maryann Martinovic; Zoltan Arany; Glenn C Rowe; Amanda Souza; Susan Cheng; Elizabeth L McCabe; Elaine Yang; Xu Shi; Rahul Deo; Frederick P Roth; Aarti Asnani; Eugene P Rhee; David M Systrom; Marc J Semigran; Ramachandran S Vasan; Steven A Carr; Thomas J Wang; Marc S Sabatine; Clary B Clish; Robert E Gerszten
Journal:  Sci Transl Med       Date:  2010-05-26       Impact factor: 17.956

2.  Glucose or intermittent high-intensity exercise in glargine/glulisine users with T1DM.

Authors:  Marie-Christine Dubé; Carole Lavoie; S John Weisnagel
Journal:  Med Sci Sports Exerc       Date:  2013-01       Impact factor: 5.411

3.  A versatile targeted metabolomics method for the rapid quantification of multiple classes of phenolics in fruits and beverages.

Authors:  Urska Vrhovsek; Domenico Masuero; Mattia Gasperotti; Pietro Franceschi; Lorenzo Caputi; Roberto Viola; Fulvio Mattivi
Journal:  J Agric Food Chem       Date:  2012-04-24       Impact factor: 5.279

4.  Development of urinary pseudotargeted LC-MS-based metabolomics method and its application in hepatocellular carcinoma biomarker discovery.

Authors:  Yaping Shao; Bin Zhu; Ruiyin Zheng; Xinjie Zhao; Peiyuan Yin; Xin Lu; Binghua Jiao; Guowang Xu; Zhenzhen Yao
Journal:  J Proteome Res       Date:  2014-12-17       Impact factor: 4.466

5.  SWATHtoMRM: Development of High-Coverage Targeted Metabolomics Method Using SWATH Technology for Biomarker Discovery.

Authors:  Haihong Zha; Yuping Cai; Yandong Yin; Zhuozhong Wang; Kang Li; Zheng-Jiang Zhu
Journal:  Anal Chem       Date:  2018-03-02       Impact factor: 6.986

6.  XCMS-MRM and METLIN-MRM: a cloud library and public resource for targeted analysis of small molecules.

Authors:  Xavier Domingo-Almenara; J Rafael Montenegro-Burke; Julijana Ivanisevic; Aurelien Thomas; Jonathan Sidibé; Tony Teav; Carlos Guijas; Aries E Aisporna; Duane Rinehart; Linh Hoang; Anders Nordström; María Gómez-Romero; Luke Whiley; Matthew R Lewis; Jeremy K Nicholson; H Paul Benton; Gary Siuzdak
Journal:  Nat Methods       Date:  2018-08-27       Impact factor: 28.547

7.  Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI).

Authors:  Lloyd W Sumner; Alexander Amberg; Dave Barrett; Michael H Beale; Richard Beger; Clare A Daykin; Teresa W-M Fan; Oliver Fiehn; Royston Goodacre; Julian L Griffin; Thomas Hankemeier; Nigel Hardy; James Harnly; Richard Higashi; Joachim Kopka; Andrew N Lane; John C Lindon; Philip Marriott; Andrew W Nicholls; Michael D Reily; John J Thaden; Mark R Viant
Journal:  Metabolomics       Date:  2007-09       Impact factor: 4.290

8.  Development and Application of Ultra-Performance Liquid Chromatography-TOF MS for Precision Large Scale Urinary Metabolic Phenotyping.

Authors:  Matthew R Lewis; Jake T M Pearce; Konstantina Spagou; Martin Green; Anthony C Dona; Ada H Y Yuen; Mark David; David J Berry; Katie Chappell; Verena Horneffer-van der Sluis; Rachel Shaw; Simon Lovestone; Paul Elliott; John Shockcor; John C Lindon; Olivier Cloarec; Zoltan Takats; Elaine Holmes; Jeremy K Nicholson
Journal:  Anal Chem       Date:  2016-08-26       Impact factor: 6.986

9.  Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis - a potential biomarker role for LysoPC.

Authors:  Barbara Rindlisbacher; Cornelia Schmid; Thomas Geiser; Cédric Bovet; Manuela Funke-Chambour
Journal:  Respir Res       Date:  2018-01-10

10.  HMDB 4.0: the human metabolome database for 2018.

Authors:  David S Wishart; Yannick Djoumbou Feunang; Ana Marcu; An Chi Guo; Kevin Liang; Rosa Vázquez-Fresno; Tanvir Sajed; Daniel Johnson; Carin Li; Naama Karu; Zinat Sayeeda; Elvis Lo; Nazanin Assempour; Mark Berjanskii; Sandeep Singhal; David Arndt; Yonjie Liang; Hasan Badran; Jason Grant; Arnau Serra-Cayuela; Yifeng Liu; Rupa Mandal; Vanessa Neveu; Allison Pon; Craig Knox; Michael Wilson; Claudine Manach; Augustin Scalbert
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

View more
  2 in total

1.  Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease.

Authors:  C Meier; K Freiburghaus; C Bovet; J Schniering; Y Allanore; O Distler; C Nakas; B Maurer
Journal:  Sci Rep       Date:  2020-12-14       Impact factor: 4.379

Review 2.  Mass spectrometry applied to diagnosis, prognosis, and therapeutic targets identification for the novel coronavirus SARS-CoV-2: A review.

Authors:  Nerilson M Lima; Bruno L M Fernandes; Guilherme F Alves; Jéssica C Q de Souza; Marcelo M Siqueira; Maria Patrícia do Nascimento; Olívia B O Moreira; Alessandra Sussulini; Marcone A L de Oliveira
Journal:  Anal Chim Acta       Date:  2021-12-20       Impact factor: 6.558

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.